Eosinophilic cellulitis (Wells' syndrome) as a cutaneous reaction to the administration of adalimumab
- 1 June 2006
- journal article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 65 (6) , 839-840
Abstract
Three to 4 hours after the second adalimumab injection (15 days later), the patient presented at the emergency department with chest discomfort, epigastralgia, fever (38.4°C), rigor, fatigue, and malaise. At the same time, at the injection site (left thigh), a violaceous plaque (10×9 cm) had developed, emerging as an erythematous urticarial oedema (fig 1A⇓). Laboratory …Keywords
This publication has 5 references indexed in Scilit:
- Adalimumab: a review of side effectsExpert Opinion on Drug Safety, 2005
- Skin reaction to adalimumabArthritis & Rheumatism, 2004
- Eosinophilic fasciitis and eosinophilic cellulitis in a patient with abnormal circulating clonal T cells: increased production of interleukin 5 and inhibition by interferon alfaJournal of the American Academy of Dermatology, 2003
- Nodular presentation of eosinophilic cellulitis (Wells' syndrome)Clinical and Experimental Dermatology, 2001
- Drugs and Wells' syndrome: a possible causal relationship?International Journal of Dermatology, 2001